Kim R Tsuchimoto - Net Worth and Insider Trading
Kim R Tsuchimoto Net Worth
The estimated net worth of Kim R Tsuchimoto is at least $5,450 dollars as of 2024-04-24. Kim R Tsuchimoto is the CFO of Raptor Pharmaceutical Corp and owns about 582 shares of Raptor Pharmaceutical Corp (RPTP) stock worth over $5,238. Kim R Tsuchimoto is also the CFO of Monopar Therapeutics Inc and owns about 325 shares of Monopar Therapeutics Inc (MNPR) stock worth over $212. Details can be seen in Kim R Tsuchimoto's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kim R Tsuchimoto has not made any transactions after 2019-12-18 and currently still holds the listed stock(s).
Transaction Summary of Kim R Tsuchimoto
Kim R Tsuchimoto Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kim R Tsuchimoto owns 3 companies in total, including Monopar Therapeutics Inc (MNPR) , Raptor Pharmaceutical Corp (RPTP) , and Spatialight Inc (SPLT) .
Click here to see the complete history of Kim R Tsuchimoto’s form 4 insider trades.
Insider Ownership Summary of Kim R Tsuchimoto
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MNPR | Monopar Therapeutics Inc | 2022-12-31 | Chief Financial Officer |
| RPTP | Raptor Pharmaceutical Corp | 2012-09-25 | other: Vice President Finance |
| SPLT | Spatialight Inc | 2005-08-01 | Prin Financial & Acctg Officer |
Kim R Tsuchimoto Latest Holdings Summary
Kim R Tsuchimoto currently owns a total of 2 stocks. Among these stocks, Kim R Tsuchimoto owns 582 shares of Raptor Pharmaceutical Corp (RPTP) as of August 29, 2012, with a value of $5,238 and a weighting of 96.11%. Kim R Tsuchimoto also owns 325 shares of Monopar Therapeutics Inc (MNPR) as of December 18, 2019, with a value of $212 and a weighting of 3.89%.
Latest Holdings of Kim R Tsuchimoto
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RPTP | Raptor Pharmaceutical Corp | 2012-08-29 | 582 | 9.00 | 5,238 |
| MNPR | Monopar Therapeutics Inc | 2019-12-18 | 325 | 0.65 | 212 |
Holding Weightings of Kim R Tsuchimoto
Kim R Tsuchimoto Form 4 Trading Tracker
According to the SEC Form 4 filings, Kim R Tsuchimoto has made a total of 0 transactions in Raptor Pharmaceutical Corp (RPTP) over the past 5 years. The most-recent trade in Raptor Pharmaceutical Corp is the sale of 3,510 shares on August 29, 2012, which brought Kim R Tsuchimoto around $17,550.
According to the SEC Form 4 filings, Kim R Tsuchimoto has made a total of 1 transactions in Monopar Therapeutics Inc (MNPR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Monopar Therapeutics Inc is the acquisition of 325 shares on December 18, 2019, which cost Kim R Tsuchimoto around $2,600.
Insider Trading History of Kim R Tsuchimoto
- 1
Kim R Tsuchimoto Trading Performance
Kim R Tsuchimoto Ownership Network
Ownership Network List of Kim R Tsuchimoto
Ownership Network Relation of Kim R Tsuchimoto
Kim R Tsuchimoto Owned Company Details
What does Monopar Therapeutics Inc do?
Who are the key executives at Monopar Therapeutics Inc?
Kim R Tsuchimoto is the Chief Financial Officer of Monopar Therapeutics Inc. Other key executives at Monopar Therapeutics Inc include director & Chief Executive Officer Chandler Robinson , other: Acting Chief Medical Officer Patrice Rioux , and Chief Operating Officer Andrew Cittadine .
Monopar Therapeutics Inc (MNPR) Insider Trades Summary
Over the past 18 months, Kim R Tsuchimoto made no insider transaction in Monopar Therapeutics Inc (MNPR). Other recent insider transactions involving Monopar Therapeutics Inc (MNPR) include a net purchase of 16,053 shares made by Andrew Cittadine ,
In summary, during the past 3 months, insiders sold 0 shares of Monopar Therapeutics Inc (MNPR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Monopar Therapeutics Inc (MNPR) were sold and 16,053 shares were bought by its insiders, resulting in a net purchase of 16,053 shares.
Monopar Therapeutics Inc (MNPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Monopar Therapeutics Inc Insider Transactions
Kim R Tsuchimoto Mailing Address
Above is the net worth, insider trading, and ownership report for Kim R Tsuchimoto. You might contact Kim R Tsuchimoto via mailing address: C/o Monopar Therapeutics Inc., 1000 Skokie Blvd., Suite 350, Wilmette Il 60091.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
